Federal contract award
15B20526P00000149
NATIONAL DRUG CODE: 73154-0130-60 GENERIC NAME: TENAPANOR 20MG TAB TRADE NAME: XPHOZAH
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FMC DEVENS |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | $0 |
| Potential contract value / ceiling | $0 |
| Start date | Aug 10, 2026 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Aug 27, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 27, 2026 | P00001 | $-4.0K | NATIONAL DRUG CODE: 73154-0130-60 GENERIC NAME: TENAPANOR 20MG TAB TRADE NAME: XPHOZAH |
| Aug 10, 2026 | 0 | $4.0K | NATIONAL DRUG CODE: 73154-0130-60 GENERIC NAME: TENAPANOR 20MG TAB TRADE NAME: XPHOZAH |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.